Halozyme Therapeutics | HALO - EPS Прибыль на акцию


Fiscal Календарь Фактический Консенсус Предыдущий Дата
FY2026Q3 Sep/2025 2.18 1.72 Nov/09
FY2026Q2 Jun/2026 2.28 1.81 1.54 Aug/06
FY2026Q1 Mar/2026 1.60 1.76 1.11 May/11
FY2025Q4 Dec/2025 -0.24 1.9 1.26 Feb/17
FY2025Q3 Sep/2025 1.72 1.59 1.27 Nov/03




Eps Изменить Дата
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
Agios Pharmaceuticals USD -1.69 0 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Amarin USD 0.14 0.06 2025-12
Amgen USD 6.29 1.14 2026-06
Baxter International USD 0.56 0.2 2026-06
Cara Therapeutics USD -0.72 0.14 2026-03
Cytokinetics USD -1.5 0.17 2026-06
DBV Technologies USD -0.55 0.31 2026-03
Eli Lilly USD 8.38 0.17 2026-06
Halozyme Therapeutics USD 2.28 0.68 2026-06
Intrexon USD -0.1 0.03 2024-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
MannKind USD -0.01 0.01 2026-06
Minerva Neurosciences USD -0.56 3.53 2024-12
Nektar Therapeutics USD -1.78 0.43 2026-03
Pfizer USD 0.77 0.02 2026-06
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
United Therapeutics USD 7.27 1.45 2026-06
Vanda Pharmaceuticals USD -0.09 0 2024-12